Literature DB >> 27018057

Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.

José María Pego-Reigosa1, Ana Lois-Iglesias2, Íñigo Rúa-Figueroa2, María Galindo2, Jaime Calvo-Alén2, Jacobo de Uña-Álvarez2, Vanessa Balboa-Barreiro2, Jesús Ibáñez Ruan2, Alejandro Olivé2, Manuel Rodríguez-Gómez2, Antonio Fernández Nebro1, Mariano Andrés2, Celia Erausquin2, Eva Tomero2, Loreto Horcada Rubio2, Esther Uriarte Isacelaya2, Mercedes Freire2, Carlos Montilla2, Ana I Sánchez-Atrio2, Gregorio Santos-Soler2, Antonio Zea2, Elvira Díez2, Javier Narváez2, Ricardo Blanco-Alonso2, Lucía Silva-Fernández2, María Esther Ruiz-Lucea2, Mónica Fernández-Castro2, José Ángel Hernández-Beriain2, Marian Gantes-Mora2, Blanca Hernández-Cruz2, José Pérez-Venegas2, Ángela Pecondón-Español2, Carlos Marras Fernández-Cid2, Mónica Ibáñez-Barcelo2, Gema Bonilla2, Vicenç Torrente-Segarra2, Iván Castellví2, Juan José Alegre2, Joan Calvet2, José Luis Marenco de la Fuente3, Enrique Raya2, Tomás Ramón Vázquez-Rodríguez2, Víctor Quevedo-Vila2, Santiago Muñoz-Fernández2, Teresa Otón2, Anisur Rahman2, Francisco Javier López-Longo2.   

Abstract

OBJECTIVES: To identify patterns (clusters) of damage manifestations within a large cohort of SLE patients and evaluate the potential association of these clusters with a higher risk of mortality.
METHODS: This is a multicentre, descriptive, cross-sectional study of a cohort of 3656 SLE patients from the Spanish Society of Rheumatology Lupus Registry. Organ damage was ascertained using the Systemic Lupus International Collaborating Clinics Damage Index. Using cluster analysis, groups of patients with similar patterns of damage manifestations were identified. Then, overall clusters were compared as well as the subgroup of patients within every cluster with disease duration shorter than 5 years.
RESULTS: Three damage clusters were identified. Cluster 1 (80.6% of patients) presented a lower amount of individuals with damage (23.2 vs 100% in clusters 2 and 3, P < 0.001). Cluster 2 (11.4% of patients) was characterized by musculoskeletal damage in all patients. Cluster 3 (8.0% of patients) was the only group with cardiovascular damage, and this was present in all patients. The overall mortality rate of patients in clusters 2 and 3 was higher than that in cluster 1 (P < 0.001 for both comparisons) and in patients with disease duration shorter than 5 years as well.
CONCLUSION: In a large cohort of SLE patients, cardiovascular and musculoskeletal damage manifestations were the two dominant forms of damage to sort patients into clinically meaningful clusters. Both in early and late stages of the disease, there was a significant association of these clusters with an increased risk of mortality. Physicians should pay special attention to the early prevention of damage in these two systems.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  RELESSER; Spanish; cluster analysis; cohort; mortality; organ damage; systemic lupus erythematosus

Mesh:

Year:  2016        PMID: 27018057     DOI: 10.1093/rheumatology/kew049

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

1.  Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus Erythematosus.

Authors:  Ju-Yang Jung; Hyun-Young Lee; Eunyoung Lee; Hyoun-Ah Kim; Dukyong Yoon; Chang-Hee Suh
Journal:  J Clin Med       Date:  2022-04-25       Impact factor: 4.964

Review 2.  Musculoskeletal involvement and ultrasonography update in systemic lupus erythematosus: New insights and review.

Authors:  Vicenç Torrente-Segarra; Tarek Carlos Salman Monte; Hèctor Corominas
Journal:  Eur J Rheumatol       Date:  2018-07

3.  Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort.

Authors:  Javier Narváez; Helena Borrell; Fernando Sánchez-Alonso; Iñigo Rúa-Figueroa; Francisco Javier López-Longo; María Galindo-Izquierdo; Jaime Calvo-Alén; Antonio Fernández-Nebro; Alejandro Olivé; José Luis Andreu; Víctor Martínez-Taboada; Joan Miquel Nolla; José María Pego-Reigosa
Journal:  Arthritis Res Ther       Date:  2018-12-19       Impact factor: 5.156

4.  Evaluating hypercoagulability in new-onset systemic lupus erythematosus patients using thromboelastography.

Authors:  Huiyun Gong; Ce Shi; Zhuochao Zhou; Jialin Teng; Yue Sun; Chengde Yang; Xuefeng Wang; Junna Ye
Journal:  J Clin Lab Anal       Date:  2019-12-16       Impact factor: 2.352

5.  Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.

Authors:  Irene E M Bultink; Frank de Vries; Ronald F van Vollenhoven; Arief Lalmohamed
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

6.  Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort.

Authors:  Beatriz Tejera Segura; Brett Sydney Bernstein; Thomas McDonnell; Chris Wincup; Vera M Ripoll; Ian Giles; David Isenberg; Anisur Rahman
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.